by Annie De Groot | Oct 27, 2020 | Thinking Out Loud -Blog
The What If Machine, as applied to Immunogenicity Well Hello Again! Our PANDA program is back in the news. Having just completed validation studies on Salmon Calcitonin and Teriparatide, we’re back in the business of predicting the future with the What If...
by Elena Iemma | Sep 21, 2023
Prospectively Assessing the Immunogenic Risk of Potential Synthetic Peptide Impurities in silico with the What-if Machine (WhIM)
by Annie De Groot | Aug 14, 2018 | Thinking Out Loud -Blog
One-on-One Interview with Brian Roberts: Scientific Director, Preclinical Immunology at EpiVax We recently sat down with our very own Scientific Director, Preclinical Immunology, Brian Roberts, to discuss his ongoing work with PANDA. In this exclusive interview, he...
by Elena Iemma | Feb 22, 2024 | Thinking Out Loud -Blog
Immunogenicity assessment is key to drug safety. Currently there is no standard approach to the In Silico Immunogenicity Assessment of Therapeutic Peptides, however, the EpiVax team has worked with the FDA to develop several methods, including a validated in silico...
by Riley Nolan | Oct 28, 2021 | Featured, Thinking Out Loud -Blog
First Class? (Class I) Are you working with mRNA, CAR-T, or gene/cell therapy? Then this is news that you can use! EpiVax has First Class HLA Class I prediction tools. Assessing the immunogenicity risk of “new modalities” includes CTL (Class I) epitopes, addition to...
by Annie De Groot | Oct 8, 2021 | Events
From October 25th to the 28th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Scientific Director of Protein Therapeutics and Aimee Mattei, Immunoinformatics Program Manager, Peptide Therapeutics. Aimee and Brian will...
by Riley Nolan | Aug 31, 2021 | Featured, Thinking Out Loud -Blog
From Disco to BTS Time flies when you are having fun! I totally missed the 10th anniversary of “Thinking Out Loud” a.k.a TOL – this newsletter. Do you want to see the first post? I hope you like disco! Lucky for you, I’ve moved on...
by Annie De Groot | Sep 10, 2019 | Events
From September 23rd to the 26th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Associate Scientific Director of Protein Therapeutics. Dr. Roberts will present two posters on Tuesday September 24th, from 3:30PM –...
by Annie De Groot | Oct 5, 2018 | News
This original article was published on October 2nd, 2018 in ConvergenceRI. PROVIDENCE, RI – The U.S. Food and Drug Administration announced on Tuesday, Oct. 2, that the federal agency has awarded EpiVax and CUBRC a $1 million contract over two years to establish best...
by Elena Iemma | Nov 27, 2023 | Featured, Thinking Out Loud -Blog
This is a two-way street Hey Hey, Hallo, Hola, Ciao, Namaste, Hello, Bonjour, Konnichiwa! When do you do your ‘thinking’ about the day? Do you do it while running? Well, I was thinking about you guys on my runs this week. I am finally back in Providence,...